Breakdown | |||||
TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
74.82B | 74.65B | 73.50B | 70.45B | 68.45B | 67.35B | Gross Profit |
15.98B | 15.97B | 14.99B | 11.82B | 15.58B | 16.43B | EBIT |
2.81B | 2.85B | 1.83B | -1.13B | 2.27B | 3.41B | EBITDA |
3.86B | 4.93B | 3.97B | 130.71M | 4.71B | 5.22B | Net Income Common Stockholders |
2.48B | 2.46B | 1.75B | -1.32B | 2.01B | 2.98B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
1.57B | 1.48B | 797.03M | 463.87M | 3.53B | 2.56B | Total Assets |
68.99B | 68.73B | 66.37B | 60.66B | 61.23B | 56.95B | Total Debt |
3.36B | 3.20B | 3.74B | 3.24B | 3.77B | 4.29B | Net Debt |
1.78B | 1.71B | 2.94B | 2.78B | 233.87M | 1.73B | Total Liabilities |
28.14B | 27.35B | 27.11B | 26.66B | 26.30B | 24.51B | Stockholders Equity |
40.85B | 41.39B | 39.26B | 34.00B | 34.93B | 32.44B |
Cash Flow | Free Cash Flow | ||||
0.00 | 1.87B | 302.81M | -2.46B | 2.07B | -1.84B | Operating Cash Flow |
0.00 | 2.47B | 904.67M | -53.46M | 3.90B | 3.53B | Investing Cash Flow |
0.00 | -680.32M | -596.29M | -2.02B | -1.92B | -5.50B | Financing Cash Flow |
0.00 | -1.10B | 24.43M | -997.37M | -994.89M | 2.42B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | ¥31.29B | 16.07 | 1.17% | 3.87% | 5.01% | ||
75 Outperform | ¥29.87B | 8.28 | 2.34% | 3.36% | 30.33% | ||
74 Outperform | ¥32.19B | 22.45 | 1.80% | 10.43% | -0.65% | ||
74 Outperform | ¥33.22B | 14.10 | 2.77% | 10.57% | 4.52% | ||
66 Neutral | ¥39.91B | 14.90 | 3.94% | 7.47% | -37.31% | ||
65 Neutral | $8.88B | 15.05 | 4.75% | 203.76% | 3.54% | -2.50% | |
60 Neutral | ¥30.30B | 12.32 | 1.86% | 1.56% | 40.56% |